Article

marketwatch.com on 2020-01-16 12:33

GlaxoSmithKline cut to underweight at Barclays

GlaxoSmithKline was downgraded to underweight from equal weight by Barclays, which said 2020 looks to be a much tougher investment year for the pharma ...

Related news